Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition - Reuters
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxQbTlMM2pBQ1Eyd01DV2xwWEl3WDRFWFdYTFNTV2dlaUFlYnV6QmgzQ0ZMOHVpUWZ1d196Z013NTUzdkNyLUEwTVdfdHdSM0t1MWZEcnZ0eVppUWhyVjFfUWVqWlhxMThHeHIyV3lQS2JYSjN0YUU3VDFCTHlGYmlRTG5FSjRweWJqLUxtOVVfbTlsSHI3dWN2VnIycXlRZ2pVcDBUZ0dTRUdBbjJPMXg2bjRTWFFNMHdJSjU4U1A5SVQ5UDFQ?oc=5" target="_blank">Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up - Reuters
AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up Reuters
September 28, 2026 at 10:15 PMMerck licenses SciBrunch cancer drug in deal worth up to $2.13 billion - Reuters
Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion Reuters
September 28, 2026 at 04:14 PMBayer to invest $2.2 billion in new US pharma site - Reuters
Bayer to invest $2.2 billion in new US pharma site Reuters
October 2, 2026 at 07:19 PMSeligman Ventures doubles capital to $1 billion as AI boom revives hardware bets - Reuters
Seligman Ventures doubles capital to $1 billion as AI boom revives hardware bets Reuters
September 28, 2026 at 05:00 PMWalgreens-owner Sycamore nears $9 billion sale of Boots, WSJ reports - reuters.com
Walgreens-owner Sycamore nears $9 billion sale of Boots, WSJ reports reuters.com
September 30, 2026 at 08:14 PMSanofi to pay Regeneron $1 billion upfront in expanded immunology deal - Reuters
Sanofi to pay Regeneron $1 billion upfront in expanded immunology deal Reuters
October 1, 2026 at 05:17 AM